Expanded polyglutamine stretches interact with TAF(II)130, interfering with CREB-dependent transcription

Nature Genetics

Volumn 26, Issue 1, 2000, Pages 29-36

  Shimohata, Takayoshi ^a   Nakajima, Toshihiro ^b,c   Yamada, Mitsunori ^a   Uchida, Chiharu ^d   Onodera, Osamu ^a   Naruse, Satoshi ^a   Kimura, Tetsuya ^a   Koide, Reiji ^a   Nozaki, Kenkichi ^a   Sano, Yasuteru ^a   Ishiguro, Hiroshi ^e   Sakoe, Kumi ^f   Ooshima, Takayuki ^b,c   Sato, Aki ^a   Ikeuchi, Takeshi ^a   Oyake, Mutsuo ^a   Sato, Toshiya ^a   Aoyagi, Yasuyuki ^a   Hozumi, Isao ^a   Nagatsu, Toshiharu ^e   Takiyama, Yoshihisa ^f   Nishizawa, Masatoyo ^f   Goto, Jun ^g   Kanazawa, Ichiro ^g   Davidson, Irwin ⁱ   Tanese, Naoko ^h   Takahashi, Hitoshi ^a   Tsuji, Shoji ^a   more..

^a NIIGATA UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e FUJITA HEALTH UNIVERSITY   (Japan)

^f JICHI MEDICAL UNIVERSITY   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MUTANT PROTEIN; NUCLEAR PROTEIN; POLYGLUTAMINE; RNA HELICASE; TATA BINDING PROTEIN;

ARTICLE; AUTOPSY; BRAIN TISSUE; CELL DEATH; CELL NUCLEUS; CYTOTOXICITY; DEGENERATIVE DISEASE; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; NERVE DEGENERATION; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANIMALS; ATROPHY; BETA-GALACTOSIDASE; BLOTTING, WESTERN; BRAIN; CELL DEATH; CELL LINE; CELL NUCLEOLUS; CELL NUCLEUS; CLONING, MOLECULAR; COS CELLS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DENTATE GYRUS; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GLOBUS PALLIDUS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEURODEGENERATIVE DISEASES; PEPTIDES; PLASMIDS; PRECIPITIN TESTS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TATA-BINDING PROTEIN ASSOCIATED FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR TFIID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRINUCLEOTIDE REPEAT EXPANSION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0033818112     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/79139     Document Type: Article

References (48)

1. Ross, C.A. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19, 1147-1150 (1997).
2. 1A-voltage-dependent calcium channel. Nature Genet. 15, 62-69 (1997).
3. Ikeda, H. et al. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13, 196-202 (1996).
4. Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506 (1996).
5. Skinner, P.J et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389, 971-974 (1997).
6. Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548 (1997).
7. DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993 (1997).
8. Paulson, H.L. et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333-344 (1997).
9. Igarashi, S. et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nature Genet. 18, 111-117 (1998).
10. Li, M. et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann. Neurol. 44, 249-254 (1998).
11. Holmberg, M. et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum. Mol. Genet 7, 913-918 (1998).
12. Koyano, S. et al. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study. Neurosci. Lett. 273, 117-120 (1999).
13. Simental, J.A, Sar, M., Lane, M.V., French, F.S. & Wilson, E.M. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J. Biol. Chem. 266, 510-518 (1991).
14. Tait, D. et al. Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Hum. Mol. Genet. 7, 991-997 (1998).
15. Miyashita, T. et al. Intracellular aggregate formation of dentatorubralpallidoluysian atrophy (DRPLA) protein with the expanded polyglutamine. Biochem. Biophys. Res. Commun. 249, 96-102 (1998).
16. Sato, A. et al. Adenovirus-mediated expression of mutant DRPLA proteins with expanded polyglutamine stretches in neuronally differentiated PC12 cells. Preferential intranuclear aggregate formation and apoptosis. Hum. Mol. Genet. 8, 997-1006 (1999).
17. Kaytor, M.D. et al. Nuclear localization of spinocerebellar ataxia type 7 protein, ataxin-7. Hum. Mol. Genet. 8, 1657-1664 (1999).
18. Goldberg, Y.P. et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13, 442-449 (1996).
19. Klement, I.A. et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice, Cell 95, 41-53 (1998).
20. Saudou, F., Finkbeiner, S., Devys, D. & Greenberg, M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66 (1998).
21. ∥100. Proc. Natl. Acad. Sci. USA 93, 13611-13616 (1996).
22. ∥135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells. Genes Dev. 11, 1381-1395 (1997).
23. Schilling, G. et al. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Neuron 24, 275-286 (1999).
24. Newmeyer, D.D. & Forbes, D.J. Nuclear import can be separated into distinct steps in vitro, nuclear pore binding and translocation. Cell 52, 641-653 (1988).
25. Nakajima, T., Uchida, C., Anderson, S.F., Parvin, J.D. & Montminy, M. Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev. 11, 738-747 (1997).
26. Brindle, P., Linke, S. & Montrniny, M. Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressers. Nature 364, 821-824 (1993).
27. Sisodia, S.S. Nuclear inclusions in glutamine repeat disorders: Are they pernicious, coincidental, or beneficial? Cell 95, 1-4 (1998).
28. Li, X.-J. et al. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398-402 (1995).
29. Kalchman, M.A. et al. HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nature Genet. 16, 44-53 (1997).
30. Matilla, A. et al. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 389, 974-978 (1997).
31. Onodera, O. et al. Oligomerization of expanded-polyglutamine domain fluorescent fusion proteins in cultured mammalian cells. Biochem. Biophys. Res. Commun. 238, 599-605 (1997).
32. Waragai, M. et al. PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival. Hum. Mol. Genet. 8, 977-987 (1999).
33. Gonzalez, G.A. & Montminy, M.R. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59, 675-680 (1989).
34. Sapp, E. et al. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 64, 397-404 (1995).
35. Timmers, H.J.L.M., Swaab, D.F., van de Nes, J.A.P. & Kremer, H.P.H. Somatostatin 1-12 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington's disease patients. Brain Res. 728, 141-148 (1996).
36. De Souza, E.B., Whitehouse, P.J., Folstein, S.E., Price, D.L. & Vale, W.W. Corticotropin-releasing hormone (CRH) is decreased in the basal ganglia in Huntington's disease. Brain Res. 437, 355-359 (1987).
37. Usdin, M.T., Shelbourne, P.F., Myers, R.M. & Madison, D.V. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum. Mol. Genet. 8, 839-846 (1999).
38. Li, S.-H., Cheng, A.L., Li, H. & Li, X.-J. Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin. J. Neurosci. 19, 5159-5172 (1999).
39. Riccio, A., Ahn, S., Davenport, CM., Blendy, J.A. & Ginty, D.D. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286, 2358-2361 (1999).
40. Bonni, A. et al. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358-1362 (1999).
41. Moulder, K.L., Onodera, O., Burke, J.R., Strittmatter, W.J. & Johnson, E.M. Jr Generation of neuronal intranuclear inclusions by polyglutamine-GFP: analysis of inclusion clearance and toxicity as a function of polyglutamine length. J. Neurosci. 19, 705-715 (1999).
42. Perez, M.K. et al. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J. Cell Biol. 143, 1457-1470 (1998).
43. Kazantsev, A., Preisinger, E., Dranovsky, A., Goldgaber, D. & Housman, D. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells, Proc. Natl Acad. Sci. USA 96, 11404-11409 (1999).
44. Gerber, H.P. et al. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263, 808-811 (1994).
45. Schiestl, R.H. & Gietz, R.D. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet 16, 339-346 (1989).
46. Dignam, J.D., Lebovitz, R.M. & Roeder, R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489 (1983).
47. Parker, D. et al. Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol. Cell. Biol. 16, 694-703 (1996).
48. Mizushima, S. & Nagata, S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18, 5322 (1990).